Firefly Neuroscience AIFF
NASDAQ AIFF
$0.94 +0.03 (+3.12%)
As of: Nov 9, 2026 · 12:40 PM EST

Firefly Neuroscience (AIFF) Convertible Debt (2024)

Updated

Firefly Neuroscience's Convertible Debt was $694,000 in Q4 2024.

Analysis

Firefly Neuroscience (AIFF) Convertible Debt (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 262.96 Bn 239.47 Bn 5.13 Bn
2 Abbott Laboratories 191.48 Bn 165.35 Bn 7.39 Bn
3 Danaher 164.52 Bn 144.17 Bn 3.84 Bn
4 Intuitive Surgical 161.08 Bn 141.37 Bn 2.08 Bn
5 Medtronic 132.40 Bn 97.65 Bn 6.34 Bn
6 Stryker 125.58 Bn 111.77 Bn 4.25 Bn
7 Boston Scientific 64.00 Bn 59.43 Bn 3.43 Bn
8 Edwards Lifesciences 60.27 Bn 43.47 Bn 1.35 Bn
9 Becton Dickinson 59.29 Bn 56.44 Bn 2.32 Bn
10 Firefly Neuroscience 19.31 Mn -112,089.28 253,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 694,000.00
API Access

Firefly Neuroscience Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=AIFF&period=max&api_key=YOUR_API_KEY